Labcorp Holdings, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Is Labcorp Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, Labcorp Holdings, Inc. shows a bullish overall technical stance with strong MACD signals and positive performance, despite some caution from Dow Theory on the monthly timeframe.

Is Labcorp Holdings, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Labcorp Holdings, Inc. is fairly valued with a P/E ratio of 28.86 and has outperformed the S&P 500 with a year-to-date return of 24.69% and a one-year return of 32.91%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 1,693.6 MM
NET SALES(Q) Highest at USD 3,527.3 MM
INTEREST COVERAGE RATIO(Q) Highest at 996.32

With ROE of 0.00%, it has a valuation with a 0.00 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 23,036 Million (Mid Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.60

Return on Equity

-999,999.00%

Price to Book

2.72

Revenue and Profits:

Net Sales:

3,527 Million

(Quarterly Results - Jun 2025)

Net Profit:

238 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-7.28%

6 Months

2.47%

1 Year

10.0%

2 Years

19.06%

3 Years

27.24%

4 Years

3.6%

5 Years

51.26%

Labcorp Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Labcorp Holdings, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Labcorp Holdings, Inc. has moved from expensive to fair. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 28.86, an EV to EBITDA of 14.80, and a PEG ratio of 0.0. In comparison, peers in the Pharmaceuticals & Biotechnology industry exhibit varying valuations, with notable competitors having different P/E ratios that reflect their market positions. In terms of performance, Labcorp has demonstrated strong returns, with a year-to-date return of 24.69% compared to the S&P 500's 13.30%, and a one-year return of 32.91% versus the S&P 500's 14.08%. This performance indicates that while Labcorp is fairly valued, it has outperformed the broader market over multiple periods, reinforcing its competitive position within the industry....

Labcorp Holdings Experiences Valuation Adjustment Amid Strong Market Performance

Labcorp Holdings, Inc. has recently adjusted its valuation, with its current price at $285.94. The company has shown strong performance over the past year, achieving a 32.91% return, significantly outperforming the S&P 500. Key financial metrics indicate Labcorp's competitive positioning within the Pharmaceuticals & Biotechnology sector.

Labcorp Holdings, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance

Labcorp Holdings, Inc. has recently revised its evaluation amid current market dynamics. The stock has shown strong performance over the past year, significantly outperforming the S&P 500. Technical indicators present mixed signals, with bullish trends in some areas and bearish indicators in others, reflecting a complex market environment.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.28%

EBIT Growth (5y)

-0.76%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

32.58%

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Sideways

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.45% vs 0.47% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 11.88% vs 48.33% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,527.30",
          "val2": "3,345.10",
          "chgp": "5.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "568.90",
          "val2": "499.20",
          "chgp": "13.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.10",
          "val2": "56.00",
          "chgp": "1.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.10",
          "val2": "-6.40",
          "chgp": "35.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "238.30",
          "val2": "213.00",
          "chgp": "11.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "113.00%",
          "val2": "99.40%",
          "chgp": "1.36%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.97% vs 2.51% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 96.40% vs -62.09% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,008.90",
          "val2": "12,161.60",
          "chgp": "6.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,037.90",
          "val2": "1,704.60",
          "chgp": "19.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "208.30",
          "val2": "199.60",
          "chgp": "4.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-51.30",
          "val2": "-398.10",
          "chgp": "87.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "747.10",
          "val2": "380.40",
          "chgp": "96.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "87.50%",
          "val2": "92.40%",
          "chgp": "-0.49%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

3,527.30

3,345.10

5.45%

Operating Profit (PBDIT) excl Other Income

568.90

499.20

13.96%

Interest

57.10

56.00

1.96%

Exceptional Items

-4.10

-6.40

35.94%

Consolidate Net Profit

238.30

213.00

11.88%

Operating Profit Margin (Excl OI)

113.00%

99.40%

1.36%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.45% vs 0.47% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 11.88% vs 48.33% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

13,008.90

12,161.60

6.97%

Operating Profit (PBDIT) excl Other Income

2,037.90

1,704.60

19.55%

Interest

208.30

199.60

4.36%

Exceptional Items

-51.30

-398.10

87.11%

Consolidate Net Profit

747.10

380.40

96.40%

Operating Profit Margin (Excl OI)

87.50%

92.40%

-0.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 6.97% vs 2.51% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 96.40% vs -62.09% in Dec 2023

All Annual Results

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

Labcorp Holdings, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

Is Labcorp Holdings, Inc. technically bullish or bearish?

Watch in Real-Time

Is Labcorp Holdings, Inc. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

Positive results in Jun 25

With ROE of 0.00%, it has a valuation with a 0.00 Price to Book Value

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Labcorp Holdings, Inc. overvalued or undervalued?

Labcorp Holdings Experiences Valuation Adjustment Amid Strong Market Performance

Labcorp Holdings, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About

Company Coordinates